Video Experimental Relacionado
Updated: Sep 10, 2025
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.3K
Nuevos tratamientos tópicos y sistémicos para la dermatitis atópica
Sara Mirali1, Aaron M Drucker1,2
1Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Resumen
Las nuevas terapias dirigidas ofrecen tratamientos más seguros y efectivos para la dermatitis atópica, una condición inflamatoria de la piel. Esta revisión abarca los inhibidores tópicos de la PDE4, los inhibidores JAK y los biológicos, que mejoran los resultados de los pacientes.
Área de la Ciencia:
- Dermatología
- Inmunología
- Farmacología
Sus antecedentes:
- La dermatitis atópica es una enfermedad inflamatoria crónica de la piel caracterizada por picazón y recidivas.
- Los tratamientos tradicionales para la dermatitis atópica a menudo implicaban una amplia inmunosupresión, lo que limitaba la aplicación a largo plazo.
- La necesidad de opciones terapéuticas más seguras y más específicas es crítica.
Objetivo del estudio:
- Revisar la eficacia y la seguridad de los nuevos agentes terapéuticos para la dermatitis atópica.
- Proporcionar una visión general de los tratamientos emergentes más allá de las opciones inmunosupresoras en general.
Principales métodos:
- Revisión de la literatura de estudios recientes sobre el tratamiento de la dermatitis atópica.
- Análisis de los datos de ensayos clínicos para nuevas clases terapéuticas.
- Síntesis de los perfiles de seguridad y eficacia de los nuevos agentes.
Principales resultados:
- Los inhibidores tópicos de la fosfodiesterasa 4 (PDE4) muestran efectos antiinflamatorios dirigidos.
- Los agonistas tópicos del receptor de hidrocarburos de arilo ofrecen un nuevo mecanismo para el manejo de la condición de la piel.
- Los inhibidores sistémicos y tópicos de Janus kinase (JAK) muestran una eficacia significativa en el tratamiento de la dermatitis atópica.
- Las terapias biológicas proporcionan inmunomodulación dirigida para la dermatitis atópica de moderada a grave.
Conclusiones:
- Las nuevas terapias dirigidas, incluidos los inhibidores de PDE4, los inhibidores de JAK y los biológicos, representan un avance significativo en el tratamiento de la dermatitis atópica.
- Estos nuevos agentes ofrecen mejores perfiles de seguridad en comparación con los inmunosupresores tradicionales, lo que permite un manejo más sostenido.
- El desarrollo de terapias dirigidas promete un mejor control a largo plazo y una mejor calidad de vida para los pacientes con dermatitis atópica.
Videos de Conceptos Relacionados
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
463
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
463
01:29Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189
01:30Hypersensitivities
1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K
01:30Skin Cancer
4.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.5K